areholders Novo Nordisk ® Capital allocation • For 2024, the total dividend per share increased 21.3% to DKK 11.40 (including interim dividend of DKK 3.50 per share paid in August 2024) • 29 th year of increasing dividend per share • CAPEX around DKK 65 billion expected in 2025 • No share buy back planned for 2025 eral Meeting should the initiation of a share buyback programme later be deemed relevant. The 2025E interim dividend
Download PDF file